2012 Core Therapeutic Module - Psychiatric Disorders

ACPE Number: 0204-0000-12-958-H01-P
Application-based: 1.0 Credit Hour
Release Date: 5/15/2012
Expiration Date: 5/15/2015

Let  ASHP’s new online core therapeutic modules help you prepare for any Board of Pharmacy Specialties (BPS) examination. Get comprehensive, practical guidance for psychiatric disorders, including bipolar, schizophrenia, and anxiety, as well as practice exam questions and references to helpful study resources.  

Featured topics in this online CE activity include:

·         Assessing benefits and risks of drug therapy considering other medication, and other patient specific factors.

·         Determining the most appropriate treatment and monitoring based on patient-specific information and the most
          current guidelines.

·         Assessing available information to identify drug-related problems and response to therapy.

·         How to identify appropriate modifications of patient-specific treatment plans based on follow up assessment.

 

Led by therapeutic experts, each of the 14 modules (ranging from 1 to 2 hours in length) can be completed consecutively or individually in any order.  The online format offers the convenience of studying at your own pace. 

Accreditation for Pharmacists

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 1 hour (0.1 CEUs) of continuing pharmacy education credit (ACPE activity #204-000-12-958-H01P).

Methods and Format

This activity is one of 14 modules in this series and can be completed consecutively or individually in any order. This online activity consists of audio and slides for one presentation, an attestation statement, and activity evaluation. Participants must view the entire presentation, complete the attestation statement and course evaluation to receive continuing pharmacy education credit. Participants may print their official statements of continuing pharmacy education credit immediately. The estimated time to complete this activity is 1 hour.

Target Audience

This activity is intended for pharmacy practitioners who are seeking to update their knowledge and skills commensurate with a board certification examination.

Activity Content

The purpose of this activity is to help participants prepare for a Board of Pharmacy Specialty (BPS) examination by providing a review of pertinent topics, practice of required skills and references to helpful study resources. Faculty will discuss therapeutic management of issues and provide resources on the disease state. The activity will assist the participant identify areas needed for in-depth review.

Learning Objectives

After participating in this application-based educational activity, participants should be able to

For patients with bipolar, schizophrenia, and/or anxiety disorders:

• Assess benefits and risks of drug therapy considering other medication, and other patient specific factors.
• Determine the most appropriate treatment and monitoring based on patient-specific information and the most current guidelines.
• Assess available information to identify drug-related problems and response to therapy.
• Identify appropriate modifications of patient-specific treatment plans based on follow up assessment.

Faculty

Catherine Johnson, Pharm.D., M.S., BCPP
Psychiatry Residency Director
William S. Middleton Memorial Veterans Hospital
Madison, Wisconsin
Clinical Instructor
University of Wisconsin-Madison School of Pharmacy
Madison, Wisconsin

Dr. Johnson, Pharm.D., M.S., BCPP, is psychiatric residency director for a PGY-2 psychiatric residency program at William S. Middleton Memorial Veterans Hospital in Madison, Wisconsin. Dr. Johnson also serves as clinical instructor at the University of Wisconsin-Madison School of Pharmacy. She also manages mental health services in five community based outpatient clinics. Dr. Johnson received her Doctor Pharmacy degree from Creighton University in 1998 and her Master of Science in Population Health Sciences at the University of Wisconsin-Madison in 2009. She completed a general practice residency and a primary care specialty residency at the Veteran Affairs (VA) Hospital in Portland, Oregon and Madison, Wisconsin (respectively). Dr. Johnson specializes in psychopharmacology with a research interest in the neurobiology of post-traumatic stress disorder. Dr. Johnson currently chairs the ASHP's Council on Therapeutics and is a charter member of the VA clinical pharmacy health services research team. Additionally, she serves on the College of Psychiatric and Neurologic Pharmacists Research Committee.

Disclosure Statement

In accordance with the Accreditation Council for Continuing Medical Education's Standards for Commercial Support and the Accreditation Council for Pharmacy Education's Guidelines for Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual or his or her spouse/partner has a financial relationship (e.g., employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring in the last 12 months with a commercial interest whose products or services may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on presentations.

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual's participation in development of content for an educational activity.

The faculty and planners report the following relationships:

Catherine Johnson, Pharm.D., M.S., BCPP
Dr. Johnson declares that she has no relationships pertinent to this activity.

Christopher Betz, Pharm.D., BCPS
Dr. Betz declares that he has no relationships pertinent to this activity.

Sandra Oh Clarke, B.S.Pharm.
Ms. Oh Clarke declares that she has no relationships pertinent to this activity.

Susan R. Dombrowski, M.S., B.S.Pharm.
Ms. Dombrowski declares that she has no relationships pertinent to this activity.

ASHP staff has no relevant financial relationships to disclose.